CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- Open-market buys, last 90 days
- $24,662
- in 1 filing
- Open-market sales, last 90 days
- $2,345,145
- in 3 filings, $969K under 10b5-1 plans
Net −$2,320,483. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Perez Jeffrey Thomas SVP, IP Affairs | Option exercise 10b5-1 | +18,878 | 457,657 | ||
| 2023-08-16 | Perez Jeffrey Thomas SVP, IP Affairs | Option exercise · Restricted Stock Unit 10b5-1 | −18,878 | 18,878 | ||
| 2023-08-16 | Thomasian Harry Jr. Chief Financial Officer | Option exercise 10b5-1 | +17,934 | 161,055 | ||
| 2023-08-16 | Thomasian Harry Jr. Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −17,934 | 17,934 | ||
| 2023-08-16 | Lehr Donald P. Chief Legal Officer | Option exercise 10b5-1 | +21,710 | 428,915 | ||
| 2023-08-16 | Lehr Donald P. Chief Legal Officer | Option exercise · Restricted Stock Units 10b5-1 | −21,710 | 21,710 | ||
| 2023-08-16 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 | +15,480 | 128,680 | ||
| 2023-08-16 | Shah Rutul R Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −15,480 | 15,480 | ||
| 2023-08-16 | Sabzevari Helen President and CEO | Option exercise 10b5-1 | +141,587 | 1,551,241 | ||
| 2023-08-16 | Sabzevari Helen President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −141,587 | 141,587 | ||
| 2023-08-16 | KIRK RANDAL J Director | Purchase | +119,411 | $1.51 | $180K | 31,837,786 |
| 2023-08-15 | KIRK RANDAL J Director | Purchase | +100,000 | $1.50 | $150K | 31,437,786 |
| 2023-08-15 | KIRK RANDAL J Director | Purchase | +80,589 | $1.53 | $123K | 31,518,375 |
| 2023-08-15 | KIRK RANDAL J Director | Purchase | +200,000 | $1.52 | $304K | 31,718,375 |
| 2023-08-14 | Hassan Fred Director | Purchase | +570,345 | $1.75 | $998K | 878,942 |
| 2023-08-14 | Frank Steven Director | Purchase | +400,000 | $1.72 | $688K | 882,358 |
| 2023-08-11 | Sabzevari Helen President and CEO | Sale 10b5-1 | −41,436 | $1.44 | $60K | 1,409,654 |
| 2023-08-10 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 | −5,429 | $1.21 | $7K | 113,200 |
| 2023-08-10 | Lehr Donald P. Chief Legal Officer | Sale 10b5-1 | −11,026 | $1.21 | $13K | 407,205 |
| 2023-08-10 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 | −6,852 | $1.21 | $8K | 143,121 |
Page 19 of 37 · 722 trades